Stock listing
NASDAQ:CNTB Connect Biopharma Holdings Limited Stock
Home listing (NASDAQ) of Connect Biopharma Holdings Limited
Follow Connect Biopharma Holdings Limited into a list and get an email when it puts out news.
Share price · NASDAQ:CNTB
$0.777 USD -0.025 (-3.1%)
Close on Nov 2, 2026
- Day range
- $0.750 – $0.810 USDNov 2, 2026
- Volume
- 522,322 sharesNov 2, 2026
- Market cap
- $48.94M USDAt the close on Nov 2, 2026 · price × 62.97M shares outstanding
- 52-week range
- $0.732 – $3.820 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $4.69M USDMedian day 963,891 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CNTB · Home | $0.777 USD | -0.025 (-3.1%) | 522,322 | $0.807 | $0.810 | $0.750 | $0.802 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:CNTB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.777 | -0.025 | -3.1% | $0.807 | $0.810 | $0.750 | 522,322 | |
| $0.802 | -0.033 | -4.0% | $0.827 | $0.875 | $0.780 | 2,503,725 | |
| $0.835 | -0.010 | -1.2% | $0.849 | $0.854 | $0.815 | 243,094 | |
| $0.845 | +0.003 | +0.3% | $0.833 | $0.858 | $0.820 | 355,896 | |
| $0.843 | -0.006 | -0.8% | $0.840 | $0.856 | $0.808 | 570,806 | |
| $0.849 | +0.082 | +10.8% | $0.785 | $0.886 | $0.750 | 1,746,486 | |
| $0.767 | +0.004 | +0.6% | $0.760 | $0.780 | $0.735 | 344,584 | |
| $0.762 | -0.036 | -4.5% | $0.800 | $0.820 | $0.732 | 1,073,284 | |
| $0.798 | -0.077 | -8.8% | $0.880 | $0.899 | $0.787 | 1,582,139 | |
| $0.875 | -0.025 | -2.7% | $0.895 | $0.920 | $0.875 | 339,531 | |
| $0.900 | -0.006 | -0.7% | $0.895 | $0.914 | $0.864 | 1,008,428 | |
| $0.906 | +0.000 | 0.0% | $0.890 | $0.909 | $0.870 | 575,614 | |
| $0.906 | -0.003 | -0.3% | $0.894 | $0.928 | $0.880 | 1,517,322 | |
| $0.909 | -0.010 | -1.1% | $0.894 | $0.928 | $0.870 | 1,098,124 | |
| $0.919 | +0.013 | +1.4% | $0.900 | $0.931 | $0.874 | 1,778,760 | |
| $0.906 | +0.036 | +4.1% | $0.908 | $0.933 | $0.880 | 1,619,945 | |
| $0.870 | -0.011 | -1.2% | $0.875 | $0.926 | $0.870 | 1,055,426 | |
| $0.881 | -0.064 | -6.8% | $0.930 | $0.957 | $0.880 | 1,212,723 | |
| $0.945 | +0.039 | +4.3% | $0.900 | $0.969 | $0.890 | 1,224,838 | |
| $0.905 | +0.007 | +0.8% | $0.886 | $0.980 | $0.850 | 1,840,787 | |
| $0.898 | -0.029 | -3.1% | $0.927 | $0.970 | $0.890 | 1,431,190 | |
| $0.927 | -0.053 | -5.4% | $0.980 | $1.080 | $0.886 | 4,196,123 | |
| $0.980 | -0.120 | -10.9% | $1.115 | $1.120 | $0.943 | 7,941,160 | |
| $1.100 | +0.108 | +10.9% | $1.890 | $1.890 | $1.070 | 165,632,579 | |
| $0.992 | -0.088 | -8.1% | $1.060 | $1.090 | $0.980 | 1,604,529 | |
| $1.080 | 0.000 | 0.0% | $1.080 | $1.110 | $1.050 | 2,464,393 | |
| $1.080 | -0.020 | -1.8% | $1.090 | $1.120 | $1.060 | 804,329 | |
| $1.100 | +0.030 | +2.8% | $1.070 | $1.110 | $1.065 | 778,220 | |
| $1.070 | -0.145 | -11.9% | $1.210 | $1.230 | $1.065 | 1,410,191 | |
| $1.215 | -0.105 | -8.0% | $1.280 | $1.280 | $1.205 | 1,223,618 | |
| $1.320 | +0.040 | +3.1% | $1.270 | $1.330 | $1.200 | 1,355,287 | |
| $1.280 | -0.010 | -0.8% | $1.250 | $1.320 | $1.250 | 1,282,861 | |
| $1.290 | +0.050 | +4.0% | $1.220 | $1.295 | $1.110 | 1,810,665 | |
| $1.240 | +0.070 | +6.0% | $1.140 | $1.380 | $1.130 | 3,427,204 | |
| $1.170 | -0.555 | -32.2% | $1.270 | $1.300 | $1.061 | 11,685,590 | |
| $1.725 | -0.315 | -15.4% | $1.790 | $1.820 | $1.580 | 2,690,609 | |
| $2.040 | -0.020 | -1.0% | $2.070 | $2.099 | $1.940 | 878,040 | |
| $2.060 | +0.050 | +2.5% | $1.990 | $2.075 | $1.910 | 768,570 | |
| $2.010 | +0.100 | +5.2% | $1.910 | $2.100 | $1.890 | 963,891 | |
| $1.910 | +0.070 | +3.8% | $1.920 | $1.970 | $1.800 | 1,192,903 | |
| $1.840 | -0.090 | -4.7% | $2.000 | $2.030 | $1.740 | 2,412,220 | |
| $1.930 | -0.830 | -30.1% | $2.830 | $2.930 | $1.900 | 3,759,862 | |
| $2.760 | +0.400 | +16.9% | $2.370 | $2.858 | $2.370 | 2,613,119 | |
| $2.360 | +0.160 | +7.3% | $2.200 | $2.415 | $2.150 | 1,977,694 | |
| $2.200 | -0.030 | -1.3% | $2.270 | $2.350 | $2.160 | 571,345 | |
| $2.230 | -0.050 | -2.2% | $2.320 | $2.320 | $2.200 | 340,766 | |
| $2.280 | -0.050 | -2.1% | $2.340 | $2.400 | $2.260 | 551,675 | |
| $2.330 | -0.120 | -4.9% | $2.470 | $2.503 | $2.330 | 396,224 | |
| $2.450 | +0.150 | +6.5% | $2.330 | $2.480 | $2.330 | 636,731 | |
| $2.300 | -0.060 | -2.5% | $2.380 | $2.380 | $2.250 | 430,034 | |
| $2.360 | +0.080 | +3.5% | $2.300 | $2.370 | $2.210 | 444,954 | |
| $2.280 | -0.180 | -7.3% | $2.480 | $2.620 | $2.260 | 573,362 | |
| $2.460 | +0.030 | +1.2% | $2.490 | $2.578 | $2.440 | 450,701 | |
| $2.430 | -0.060 | -2.4% | $2.500 | $2.570 | $2.415 | 320,303 | |
| $2.490 | -0.060 | -2.4% | $2.570 | $2.610 | $2.470 | 578,302 | |
| $2.550 | +0.010 | +0.4% | $2.540 | $2.570 | $2.360 | 212,200 | |
| $2.540 | +0.210 | +9.0% | $2.330 | $2.640 | $2.330 | 805,556 | |
| $2.330 | +0.090 | +4.0% | $2.250 | $2.375 | $2.240 | 371,986 | |
| $2.240 | +0.090 | +4.2% | $2.150 | $2.250 | $2.130 | 315,524 | |
| $2.150 | -0.055 | -2.5% | $2.200 | $2.235 | $2.110 | 520,290 | |
| $2.205 | +0.015 | +0.7% | $2.200 | $2.240 | $2.160 | 337,477 | |
| $2.190 | +0.010 | +0.5% | $2.180 | $2.250 | $2.130 | 552,244 | |
| $2.180 | +0.110 | +5.3% | $2.120 | $2.220 | $2.065 | 528,448 | |
| $2.070 | +0.100 | +5.1% | $2.050 | $2.140 | $2.040 | 267,730 | |
| $1.970 | -0.050 | -2.5% | $2.060 | $2.090 | $1.955 | 259,404 |
- Ticker
- NASDAQ:CNTB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 30, 2026
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
Latest deck · Sep 30, 2026
Corporate Update (September 2026)
Corporate update · 54 slides
Calls
Replays
Connect Biopharma Holdings (NASDAQ:CNTB) Q2 2021 Earnings Call
Wed, Sep 01, 2021 · 8:30 AM ET
Watch Transcript
Latest news
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
Sep 30, 2026
Closed $1.10 (+10.9%) on Sep 30, 2026
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation
Sep 15, 2026
Closed $1.17 (-32.2%) on Sep 15, 2026
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026
Closed $1.84 (-4.7%) on Sep 4, 2026
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 12, 2026
Closed $2.54 (+9.0%) on Aug 13, 2026
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
Jun 17, 2026
Closed $2.08 (+4.5%) on Jun 17, 2026
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
May 12, 2026
Closed $2.45 (-8.6%) on May 13, 2026
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Closed $2.68 (+14.5%) on May 12, 2026
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
Apr 23, 2026
Closed $2.52 (-3.1%) on Apr 23, 2026
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
Mar 31, 2026
Closed $2.62 (-9.7%) on Mar 31, 2026
Decks
Corporate Update (September 2026)
Corporate update · 54 slides · Sep 30, 2026
Technical Presentation (September 2026)
Technical · 15 slides · Sep 30, 2026
Technical Presentation (September 2026)
Technical · 16 slides · Sep 15, 2026
Investor Presentation (June 2023)
Investor deck · 40 slides · Jun 5, 2023
Connect Biopharma Holdings Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 84 in all · newest Sep 30, 2026 · oldest 2021
- Calls
- 1 call with a replay · 1 with a transcript · latest Sep 1, 2021
- Decks
- 9 decks · latest Sep 30, 2026
Where Connect Biopharma Holdings Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CNTB · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CNTB | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Connect Biopharma Holdings Limited.